BlackRock Health Sciences Trust (BME) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BlackRock Health Sciences Trust (BME) has a cash flow conversion efficiency ratio of -0.017x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.45 Million) by net assets ($568.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BME equity financing ratio to measure how much of total assets are equity-financed.
BlackRock Health Sciences Trust - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how BlackRock Health Sciences Trust's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of BlackRock Health Sciences Trust to evaluate the quality of earnings relative to operating cash generation.
BlackRock Health Sciences Trust Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BlackRock Health Sciences Trust ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui Transport Consulting &
SHG:603357
|
0.009x |
|
Almendral
SN:ALMENDRAL
|
0.078x |
|
Materials Analysis Technology
TWO:3587
|
0.112x |
|
Lifecome Biochemistry Co Ltd
SHE:002868
|
-1.583x |
|
Metallurgical Corporation of China Ltd
F:6MT
|
0.038x |
|
Benakat Petroleum Energy
JK:BIPI
|
0.044x |
|
Mnc Land Tbk
JK:KPIG
|
0.018x |
|
SandRidge Energy Inc
NYSE:SD
|
0.038x |
Annual Cash Flow Conversion Efficiency for BlackRock Health Sciences Trust (2006–2025)
The table below shows the annual cash flow conversion efficiency of BlackRock Health Sciences Trust from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see BME market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $568.30 Million | $-4.35 Million | -0.008x | -108.98% |
| 2024-12-31 | $768.57 Million | $65.52 Million | 0.085x | +56.59% |
| 2023-12-31 | $588.14 Million | $32.02 Million | 0.054x | +3838.40% |
| 2022-12-31 | $600.20 Million | $-874.04K | -0.001x | +95.77% |
| 2021-12-31 | $625.77 Million | $-21.56 Million | -0.034x | +2.82% |
| 2020-12-31 | $545.94 Million | $-19.35 Million | -0.035x | -311.19% |
| 2019-12-31 | $1.64 Billion | $-14.10 Million | -0.009x | -248.27% |
| 2018-12-31 | $352.67 Million | $2.05 Million | 0.006x | +264.94% |
| 2017-12-31 | $331.86 Million | $-1.17 Million | -0.004x | -147.50% |
| 2016-12-31 | $270.69 Million | $2.01 Million | 0.007x | +72.61% |
| 2015-12-31 | $297.53 Million | $1.28 Million | 0.004x | -98.87% |
| 2014-12-31 | $303.10 Million | $115.30 Million | 0.380x | +485.01% |
| 2013-12-31 | $270.16 Million | $17.57 Million | 0.065x | -13.63% |
| 2012-12-31 | $218.38 Million | $16.44 Million | 0.075x | +138.74% |
| 2008-12-31 | $179.64 Million | $-34.91 Million | -0.194x | -222.24% |
| 2007-12-31 | $230.28 Million | $36.61 Million | 0.159x | +34.62% |
| 2006-12-31 | $208.15 Million | $24.58 Million | 0.118x | -- |
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or d… Read more